- Home
- INAB vs TOI Comparison
INAB vs TOI Comparison
Compare INAB & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- TOI
- Stock Information
- Founded
- INAB 2016
- TOI 2007
- Country
- INAB United States
- TOI United States
- Employees
- INAB N/A
- TOI N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- TOI Medical/Nursing Services
- Sector
- INAB Health Care
- TOI Health Care
- Exchange
- INAB Nasdaq
- TOI Nasdaq
- Market Cap
- INAB 24.0M
- TOI 22.6M
- IPO Year
- INAB 2021
- TOI N/A
- Fundamental
- Price
- INAB $0.26
- TOI $0.70
- Analyst Decision
- INAB Strong Buy
- TOI Strong Buy
- Analyst Count
- INAB 3
- TOI 1
- Target Price
- INAB $7.75
- TOI $2.50
- AVG Volume (30 Days)
- INAB 893.3K
- TOI 957.0K
- Earning Date
- INAB 03-13-2025
- TOI 11-13-2024
- Dividend Yield
- INAB N/A
- TOI N/A
- EPS Growth
- INAB N/A
- TOI N/A
- EPS
- INAB N/A
- TOI N/A
- Revenue
- INAB N/A
- TOI $378,933,000.00
- Revenue This Year
- INAB N/A
- TOI $29.17
- Revenue Next Year
- INAB N/A
- TOI $16.43
- P/E Ratio
- INAB N/A
- TOI N/A
- Revenue Growth
- INAB N/A
- TOI 22.29
- 52 Week Low
- INAB $0.22
- TOI $0.13
- 52 Week High
- INAB $1.74
- TOI $2.45
- Technical
- Relative Strength Index (RSI)
- INAB 40.24
- TOI 89.45
- Support Level
- INAB $0.27
- TOI $0.25
- Resistance Level
- INAB $0.33
- TOI $0.50
- Average True Range (ATR)
- INAB 0.04
- TOI 0.09
- MACD
- INAB -0.00
- TOI 0.04
- Stochastic Oscillator
- INAB 5.70
- TOI 91.74
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.